Which antidotes are available for the novel oral anticoagulants

Rebekah Thomas; Renzo Gonzalez

doi:10.1097/01.JAA.0000484309.11932.5e

Which antidotes are available for the novel oral anticoagulants

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of the American Academy of Physician Assistants
Volume	29
DOIs	https://doi.org/10.1097/01.JAA.0000484309.11932.5e
State	Published - Jul 1 2016

Disciplines

Critical Care
Medicine and Health Sciences

Access to Document

10.1097/01.JAA.0000484309.11932.5eLicense: Unspecified

Cite this

@article{6952443823f247958344b96eee0aca7e,

title = "Which antidotes are available for the novel oral anticoagulants",

author = "Rebekah Thomas and Renzo Gonzalez",

note = "Abstract: Use of novel (or target-specific) oral anticoagulants continues to increase. This article reviews idarucizumab and andexanet alfa, two antidotes...",

year = "2016",

month = jul,

day = "1",

doi = "10.1097/01.JAA.0000484309.11932.5e",

language = "American English",

volume = "29",

journal = "Journal of the American Academy of Physician Assistants",

}

TY - JOUR

T1 - Which antidotes are available for the novel oral anticoagulants

AU - Thomas, Rebekah

AU - Gonzalez, Renzo

N1 - Abstract: Use of novel (or target-specific) oral anticoagulants continues to increase. This article reviews idarucizumab and andexanet alfa, two antidotes...

PY - 2016/7/1

Y1 - 2016/7/1

UR - http://europepmc.org/abstract/MED/27351643

U2 - 10.1097/01.JAA.0000484309.11932.5e

DO - 10.1097/01.JAA.0000484309.11932.5e

M3 - Article

VL - 29

JO - Journal of the American Academy of Physician Assistants

JF - Journal of the American Academy of Physician Assistants

ER -

Which antidotes are available for the novel oral anticoagulants

Disciplines

Access to Document

Other files and links

Cite this